0.0605
+0.0380
+(447.06%)
As of 1:31:05 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
118.3500
126.6670
Operating Expense
3,063.0070
3,063.0070
3,028.9520
5,278.2210
5,716.0990
Operating Income
-3,063.0070
-3,063.0070
-3,028.9520
-5,159.8710
-5,589.4320
Net Non Operating Interest Income Expense
1.0390
1.0390
-192.8100
-205.2490
-395.0250
Pretax Income
-3,418.8970
-3,418.8970
-4,456.3330
-8,940.7200
-7,246.1750
Tax Provision
-497.1020
-497.1020
-648.9020
-766.8140
-386.2480
Net Income Common Stockholders
-2,921.7950
-2,921.7950
-3,807.4310
-8,173.9050
-6,859.9270
Diluted NI Available to Com Stockholders
-2,921.7950
-2,921.7950
-3,807.4310
-8,173.9050
-6,859.9270
Basic EPS
-0.01
-0.01
-0.01
-0.03
-0.03
Diluted EPS
-0.01
-0.01
-0.01
-0.03
-0.03
Basic Average Shares
327,121.9940
362,004.5510
302,912.9030
251,164.3610
200,176.1560
Diluted Average Shares
327,121.9940
362,004.5510
302,912.9030
251,164.3610
200,176.1560
Total Operating Income as Reported
-3,063.0070
-3,063.0070
-3,028.9520
-6,586.9550
-5,589.4320
Total Expenses
3,063.0070
3,063.0070
3,028.9520
5,278.2210
5,716.0990
Net Income from Continuing & Discontinued Operation
-2,921.7950
-2,921.7950
-3,807.4310
-8,173.9050
-6,859.9270
Normalized Income
-2,618.7763
-2,618.7763
-2,766.3678
-4,904.5547
-5,803.0873
Interest Income
3.0250
3.0250
0.9070
0.6510
41.0890
Interest Expense
1.9860
1.9860
2.0360
124.0630
230.8280
Net Interest Income
1.0390
1.0390
-192.8100
-205.2490
-395.0250
EBIT
-3,416.9110
-3,416.9110
-4,454.2970
-8,816.6570
-7,015.3470
EBITDA
-3,379.3040
-3,379.3040
-4,336.7340
-8,702.5380
-6,844.3930
Reconciled Depreciation
37.6070
37.6070
117.5630
114.1190
170.9540
Net Income from Continuing Operation Net Minority Interest
-2,921.7950
-2,921.7950
-3,807.4310
-8,173.9050
-6,859.9270
Total Unusual Items Excluding Goodwill
-354.5730
-354.5730
-1,218.4920
-3,576.0560
-1,116.3450
Total Unusual Items
-354.5730
-354.5730
-1,218.4920
-3,576.0560
-1,116.3450
Normalized EBITDA
-3,024.7310
-3,024.7310
-3,118.2420
-5,126.4820
-5,728.0480
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0001
0.0001
Tax Effect of Unusual Items
-51.5543
-51.5543
-177.4288
-306.7057
-59.5053
12/31/2020 - 12/20/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.5850
0.00%
1GDA.F Zevra Therapeutics, Inc.
7.40
-3.27%
CVAC.VI CureVac N.V.
3.6080
-3.84%
471A.F aTyr Pharma, Inc.
3.4200
+1.18%
2Q5.BE Enochian BioSciences Inc
0.8460
-0.24%
HQ1.MU Oruka Therapeutics Inc. R
11.80
-3.28%
ORN.F Oryzon Genomics S.A.
1.4660
+3.97%
PH4.F CStone Pharmaceuticals
0.2860
0.00%
4FR.BE Faron Pharmaceuticals Oy
2.1900
-0.90%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4700
-3.09%